The experimental results show that both the CsA and the glycyrol treatments reduced the mean arthritis scores (Figure 1A), and reduced the contents of IL-1β, TNF-α, IL-6, and IL-17(Figure 1C) in the serum. The gene discussed is IL1B; the disease is arthritic joint disease.